- Design
- Systematic review and meta-analysis of 12 randomised trials
- Population
- 1425 adults with liver abscess
- Primary outcome
- Clinical treatment success and procedure-related complications
- Effect
- Success OR 4.12 (95% CI 2.01 to 8.45; I² 56%); complications OR 1.02 (0.30 to 3.50)
A meta-analysis pooled 12 randomised trials of 1425 adults with liver abscess, comparing percutaneous catheter drainage with percutaneous needle aspiration.
Catheter drainage was about four times as likely to achieve clinical success. The benefit held in subgroups by abscess size and by cause. Procedure-related complications were no more frequent with catheters. Heterogeneity across trials was moderate.
In India, where liver abscess — amoebic and pyogenic — is common and needle aspiration remains widely used, this supports catheter drainage as the first percutaneous intervention when drainage is indicated. Small abscesses, especially amoebic ones that respond to drugs alone, may still not need drainage at all; this analysis compares two drainage methods, not drainage against medical treatment. The trials' quality and blinding are not reported in the abstract.
- Prefer catheter drainage to needle aspiration when a liver abscess needs percutaneous drainage.
- Avoid planning serial needle aspirations as the default for larger abscesses.
- Continue appropriate antimicrobials, including amoebicidal and luminal agents where amoebic abscess is suspected, alongside drainage.
- Remember that many small amoebic abscesses settle with medical treatment alone and may need no drainage.
- Review catheter output and repeat imaging to decide when to remove the drain.
Why it matters
Needle aspiration remains a common first choice, and a failed aspiration means another procedure and a longer illness.
Don't overread it
This compares two drainage methods; it does not show that every liver abscess needs drainage rather than drugs alone.
The statistics, in plain English
An odds ratio of 4.12 (95% CI 2.01 to 8.45) is a large, consistent benefit. I² of 56% means the trials varied moderately in their results, though all pointed the same way. The complication odds ratio of 1.02 has a wide interval (0.30 to 3.50), so a modest difference in either direction cannot be excluded.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for radiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free